NCT05361668 2026-03-19
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Phase 2 Completed
Clinical Trials
6 trialsNCT06860269 2026-02-10
GRAALL-2024
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Recruiting
NCT06348719 2025-09-15
ROBOT-ECO-GYN
Rennes University Hospital
Phase NA Recruiting
NCT06550739 2024-08-13
Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
Chongqing University Cancer Hospital
Completed
NCT02812641 2019-03-11
Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC
National Taiwan University Hospital
Phase 2 Unknown
NCT02590315 2019-01-31
ProteusDonna
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Phase 4 Unknown